来鲁华_物理化学研究所_北京大学化学与分子工程学院

来自 : www.chem.pku.edu.cn/szll/zzjs/ 发布时间：2021-03-25

Pei, J. F.; Yin, N.; Ma, X. M.; Lai, L. H.*, Systems Biology Brings New Dimensions for Structure-Based Drug Design. J. Am. Chem. Soc. 136, 11556-11565, 2014. Zhou, L.; Bosscher, M.; Zhang, C. S.; Ozcubukcu, S.; Zhang, L.; Zhang, W.; Li, C. J.; Liu, J. Z.; Jensen, M. P.; Lai, L. H.*; He, C.* , A protein engineered to bind uranyl selectively and with femtomolar affinity. Nature Chem. 6, 236-241, 2014. Zhang, C. S.; Shen, Q.; Tang, B.; Lai, L. H.*, Computational design of helical peptides targeting TNFa. Angew. Chem. Int. Ed. Engl. 52, 11059-11062, 2013. Bi, S. Y.; Yu, D. Q.; Si, G. W.; Luo, C. X.; Li, T. Q.; Ouyang, Q.; Jakovljevic, V.; Sourjik, V.; Tu, Y. H.*; Lai, L. H.*, Discovery of novel chemoeffectors and rational design of Escherichia coli chemoreceptor specificity. Proc. Natl. Acad. Sci. USA 110, 16814-16819, 2013. Jin, F.; Yu, C.; Lai, L. H.*; Liu, Z. R.*; Ligand clouds around protein clouds: a scenario of ligand binding with intrinsically disordered proteins. PLoS Comput. Biol. 9, e1003249, 2013. Wu, Y. R.; He, C.; Gao, Y.; He, S.; Liu, Y.; Lai, L. H.*, Dynamic Modeling of Human 5-Lipoxygenase-Inhibitor Interactions Helps To Discover Novel Inhibitors. J. Med. Chem. 55 (6), 2597-2605, 2012. Qi, Y. F.; Wang, Q.; Tang, B.; Lai, L. H.*, Identifying Allosteric Binding Sites in Proteins with a Two-State G(o)over-bar Model for Novel Allosteric Effector Discovery. J. Chem. Theo. Comp. 8 (8), 2962-2971, 2012. Yuan, Y. X.; Pei, J. F.*; Lai, L. H.*, LigBuilder 2: A Practical de Novo Drug Design Approach. J. Chem. Inf. Model., 51 (5), 1083-1091, 2011. Li, C. M.; Qi, Y. F.; Teng, X.; Yang, Z. C.; Wei, P.; Zhang, C. S.; Tan, L.; Zhou, L.; Liu, Y.; Lai, L. H.*, Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase. J. Biol. Chem. 285 (36), 28134-28140, 2010. Liang, H. H.; Chen, H.; Fan, K. Q.; Wei, P.; Guo, X. R.; Jin, C. W.; Zeng, C.; Tang, C.; Lai, L. H.*, De Novo Design of a beta alpha beta Motif. Angew. Chem. Int. Ed. Engl. 48 (18), 3301-3303, 2009. Yang, K.; Bai, H. J.; Qi, O. Y.; Lai, L. H.*; Tang, C., Finding multiple target optimal intervention in disease-related molecular network. Mol. Syst. Biol. 4, 228, 2008. Wei, D. G.; Jiang, X. L.; Zhou, L.; Chen, J.; Chen, Z.; He, C.; Yang, K.; Liu, Y.; Pei, J. F.; Lai, L. H.*, Discovery of Multitarget Inhibitors by Combining Molecular Docking with Common Pharmacophore Matching. J. Med. Chem. 51 (24), 7882-7888, 2008. Zhang, Z. Q.; Chen, H.; Lai, L. H.*, Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics 23 (17), 2218-2225, 2007. Liu, S.; Liu, S. Y.; Zhu, X. L.; Liang, H. H.; Cao, A. N.; Chang, Z. J.; Lai, L. H.*, Nonnatural protein-protein interaction-pair design by key residues grafting. Proc. Natl. Acad. Sci. USA 104 (13), 5330-5335, 2007. Lai, L. H.*; Han, X. F.; Chen, H.; Wei, P.; Huang, C. K.; Liu, S. Y.; Fan, K. Q.; Zhou, L.; Liu, Z. M.; Pei, J. F.; Liu, Y., Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase. Curr. Pharm. Design. 12 (35), 4555-4564, 2006.